Edition:
United Kingdom

Oasmia Pharmaceutical AB (OASM.OQ)

OASM.OQ on NASDAQ Stock Exchange Capital Market

1.75USD
13 Aug 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.75
Open
$1.78
Day's High
$1.78
Day's Low
$1.75
Volume
63
Avg. Vol
5,450
52-wk High
$3.10
52-wk Low
$0.80

Chart for

About

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company’s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. The Animal Health area focuses on developing cancer... (more)
No analyst recommendations are available for .

Overall

Beta: 1.50
Market Cap(Mil.): kr478.06
Shares Outstanding(Mil.): 176.41
Dividend: --
Yield (%): --

Financials

  OASM.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -1.28 -- --
ROI: -44.58 15.07 14.61
ROE: -44.58 16.60 16.33

BRIEF-Oasmia Pharmaceutical Q3 sales rise, smaller operating loss

* Q3 ‍CONSOLIDATED NET SALES AMOUNTED TO TSEK 656 COMPARED TO TSEK 36 IN Q3 PREVIOUS YEAR​

02 Mar 2018

BRIEF-Oasmia Pharma says all patients have been treated in two ongoing studies with Docecal

* REG-OASMIA PHARMACEUTICAL’S DOCECAL PROGRAM ACHIEVES SIGNIFICANT DEVELOPMENT MILESTONE

19 Feb 2018

Earnings vs. Estimates